Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.2 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |